01806nam0 2200361 i 450 SUN011466820180209092412.3070.00N978-3-319-07254-820180208d2016 |0engc50 baengCH|||| |||||*Elements of probability and statisticsan introduction to probability with de Finetti’s approach and to bayesian statisticsFrancesca Biagini, Massimo Campanino[Cham] : Springer, 2016XV246 p.ill. ; 24 cmPubblicazione in formato elettronico001SUN01045612001 *UnitextLa matematica per il 3+298210 MilanoSpringer.60-XXProbability theory and stochastic processes [MSC 2020]MFSUNC02042862-XXStatistics [MSC 2020]MFSUNC02299862C12Empirical decision procedures; empirical Bayes procedures [MSC 2020]MFSUNC02644860J20Applications of Markov chains and discrete-time Markov processes on general state spaces (social mobility, learning theory, industrial processes, etc.) [MSC 2020]MFSUNC02936760J05Discrete-time Markov processes on general state spaces [MSC 2020]MFSUNC033865CHChamSUNL001889Biagini, FrancescaSUNV078642321758Campanino, MassimoSUNV078643721892SpringerSUNV000178650ITSOL20201026RICAhttp://dx.doi.org/10.1007/978-3-319-07254-8SUN0114668BIBLIOTECA CENTRO DI SERVIZIO SBA15CONS SBA EBOOK 2218 15EB 2218 20180208 Elements of probability and statistics1523290UNICAMPANIA04112nam 2200913z- 450 9910619470303321202210253-0365-5390-8(CKB)5670000000391571(oapen)https://directory.doabooks.org/handle/20.500.12854/93224(oapen)doab93224(EXLCZ)99567000000039157120202210d2022 |y 0engurmn|---annantxtrdacontentcrdamediacrrdacarrierUpdates in Management of SARS-CoV-2 InfectionMDPI - Multidisciplinary Digital Publishing Institute20221 online resource (198 p.)3-0365-5389-4 Severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) has spread worldwide from the beginning of 2020. The infection is mostly asymptomatic but some patients may develop COVID‑19 (coronavirus disease 2019) with a severe or critical course leading to pneumonia, acute respiratory distress syndrome, and multiorgan failure. Apart from the virus‑related damage of the lungs, pathomechanism of the disease seems to be linked to thromboembolism and inflammation accompanied by overproduction of proinflammatory cytokines, termed a cytokine storm, responsible for multiorgan damage and death. Since the development of a new therapeutic molecule, dedicated strictly to a particular virus is time‑consuming, physicians and scientists have started to test and repurpose old medications. Unfortunately, after one year of pandemics, there is still a lack of optimal therapy and no clear indicators of recovery. A major issue is also insufficient knowledge on predictors of the severe or deadly course of the disease, which could also help to switch from one therapeutic option to another. Due to many gaps still existing in the management of COVID-19, there is a need for the accumulation of new data particularly from real-world experience, which could be applicable to practice guidelines. The objective of this special issue of the Journal of Clinical Medicine is to provide an update on the mangement for the diagnostic workup and pharmacotherapy of SARS‑CoV‑2 infection.Medicinebicsscangiotensin 1 receptor (AT1R)angiotensin IIantigen detectionartificial intelligenceAT1R concentrationCharlson Comorbidities Indexchildrenclinical outcomeclinical presentationcluster analysisco-infectionscoronavirus disease 2019coronavirus disease 2019 (COVID-19)COVID-19COVID-19 diagnosisCOVID-19 pneumoniacritical carecytokinesCytomegalovirusdiagnosisepidemiologyindividualized managementinflammationinterleukin-6kidney failureliver functional testsliver markerslongitudinal clustermedical imagingmeta-analysismethodological credibilitymorbiditymortalityn/apandemicPCR testpersonalized medicineprognosisrapid diagnostic testSARS-CoV-2severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)severitysymptomatologysymptoms' severitysystematic umbrella reviewtherapytocilizumabtrial sequential analysisMedicineFlisiak Robertedt1328782Flisiak RobertothBOOK9910619470303321Updates in Management of SARS-CoV-2 Infection3038948UNINA